| 1 | == Agenda == |
| 2 | |
| 3 | 1. **[wiki:Research/DesignStudy/Meetings/2020/2020-12-15 Notes of previous meetings] and actions ** \\ |
| 4 | - Status of actions: |
| 5 | - None recorded. |
| 6 | |
| 7 | 2. **Updates:** |
| 8 | - // Any update: All // |
| 9 | |
| 10 | 3. ** Radiobiology programme and articulation of LhARA USPs: J. Parsons, A. Giacca** |
| 11 | |
| 12 | 4. ** Status and progress in key LhARA development themes: ** \\ |
| 13 | 1 // __Evaluation of the benefits of the initiative & optimisation of the R&D programme:__ // S. Green, P. Price \\ |
| 14 | 2 // __Development of next steps in LhARA accelerator R&D programme:__// C. Whyte, J. Pasternak \\ |
| 15 | 3 // __Proton- and ion-acoustic imaging:__ J. Bamber, P. Beard \\ |
| 16 | 4 // __ Outline Conceptual Design Report for the PoP biological-assessment facility:__ // R. McLauchlan, T. Price \\ |
| 17 | |
| 18 | 5. ** DoNM **: |
| 19 | * 16Feb21; 14:00 GMT |
| 20 | |
| 21 | 6. **AOB** |
| 22 | - None |
| 23 | |
| 24 | A. ** Summary/outreach documents: ** |
| 25 | Reminders: |
| 26 | * __[https://ccap.hep.ph.ic.ac.uk/trac/raw-attachment/wiki/Research/DesignStudy/Meetings/2020/2020-11-24/2020-11-23a-LhARA-mission.pdf Mission statement]:__ S. Green |
| 27 | * __[raw-attachment:2020-11-16:LhARA-timeline.pdf Timeline: today to clinical system]:__ K.Long, T.Kolkalova-Wheldon |
| 28 | * __PPI Strategy:__ H.Hall, G.Jones |
| 29 | * __Industrial strategy:__ F.Jamieson, S.Towe |
| 30 | * __Stakeholder plan:__ P.Price, S.Green, K. Long |
| 31 | |
| 32 | ---- |